This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
Consolidated Balance Sheets (Unaudited)
Consolidated Balance Sheets (Unaudited) (Parenthetical)
Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
Consolidated Statements of Stockholders' Equity (Unaudited)
Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Nature of Business
Summary of Significant Accounting Policies
Fair Value of Financial Instruments
Available-for-Sale Investments
Property and Equipment, Net
Accrued Expenses
Stockholders' Equity
Equity-based Compensation and Equity Incentive Plans
AbbVie Collaboration Agreement
Net Loss per Share
Commitments and Contingencies
Related Party Transactions
Subsequent Event
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Fair Value of Financial Instruments (Tables)
Available-for-Sale Investments (Tables)
Property and Equipment, Net (Tables)
Accrued Expenses (Tables)
Equity-based Compensation and Equity Incentive Plans (Tables)
Net Loss per Share (Tables)
Commitments and Contingencies (Tables)
Notes Details
Nature of Business - Additional Information (Detail)
Summary of Significant Accounting Policies - Additional Information (Detail)
Fair Value of Financial Instruments - Schedule of Company's Classified Assets Measured at Fair Value on Recurring Basis (Detail)
Available-for-Sale Investments - Summary of Available-for-Sale Securities Held (Detail)
Available-for-Sale Investments - Additional Information (Detail)
Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail)
Accrued Expenses - Schedule of Accrued Expenses (Detail)
Stockholders Equity - Additional Information (Detail)
Equity-based Compensation and Equity Incentive Plans - Additional Information (Detail)
Equity-based Compensation and Equity Incentive Plans - Schedule of Stock Option Activity Under 2015 and 2017 Plan (Detail)
Equity-based Compensation and Equity Incentive Plans - Schedule of Restricted Common Stock Activity (Detail)
Equity-based Compensation and Equity Incentive Plans - Schedule of Equity-based Compensation Expenses (Detail)
Equity-based Compensation and Equity Incentive Plans - Schedule of Equity-based Compensation Expenses by Award Type (Detail)
AbbVie Collaboration Agreement - Additional Information (Detail)
Net Loss per Share - Additional Information (Detail)
Net Loss per Share - Schedule of Potentially Common Shares Excluded from Calculation of Net Loss Per share (Detail)
Commitments and Contingencies - Additional Information (Detail)
Commitments and Contingencies - Components of Lease Cost for Operating and Finance Leases (Detail)
Commitments and Contingencies - Summary of Weighted Average Remaining Lease Term and Weighted Average Discount Rate for Operating and Finance Leases (Detail)
Commitments and Contingencies - Summary of Maturity of Lease Liabilities for Operating and Finance Leases (Detail)
Commitments and Contingencies - Schedule of Aggregate Future Lease Payments for Operating and Capital Leases (Detail)
Related Party Transactions - Additional Information (Detail)
Subsequent Event - Additional Information (Detail)
All Reports